CST Guide:
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Section I: Research Areas<br />
chapter 02: Signaling<br />
ALK, an RTK that forms oncogenic fusion proteins with<br />
EML4, TFG, and KIF5B, is expressed in lung carcinoma.<br />
ALK (D5F3 ® ) XP ® Rabbit mAb #3633: IHC<br />
analysis of paraffin-embedded human lung<br />
carcinoma with high (left) and low (right) levels<br />
of ALK expression using #3633.<br />
Phospho-Jak2 (Tyr1008) (D4A8) Rabbit<br />
mAb #8082: WB analysis of extracts from<br />
BaF3 cells (A), untreated or treated with Mouse<br />
Interleukin-3 (mIL-3) #8923 (10 ng/ml, 5 min),<br />
using #8082 (upper) or total Jak2 (D2E12) XP ®<br />
Rabbit mAb #3230 (lower).<br />
Jak2 (D2E12) XP ® Rabbit mAb #3230:<br />
Confocal IF analysis of K-562 cells (B) using<br />
#3230 (green). Blue pseudocolor = DRAQ5 ®<br />
(fluorescent DNA dye).<br />
A<br />
kDa<br />
200<br />
140<br />
100<br />
80<br />
60<br />
50<br />
40<br />
30<br />
200<br />
140<br />
100<br />
Phospho-<br />
Jak2<br />
(Tyr1008)<br />
Jak2<br />
B<br />
Treatment with<br />
IL-3 results in<br />
phosphorylation<br />
of Jak2 at Tyr1008.<br />
80<br />
60<br />
50<br />
40<br />
Ligand activation of<br />
Met, a high affinity RTK<br />
for hepatocyte growth<br />
factor (HGF), results<br />
in phosphorylation at<br />
Tyr1234/1235.<br />
A kDa<br />
200<br />
140<br />
100<br />
80<br />
60<br />
50<br />
40<br />
Phospho-Met<br />
(Tyr1234/5)<br />
B<br />
Phospho-Met (Tyr1234/1235) (D26) XP ® Rabbit mAb #3077: WB analysis of cell<br />
extracts from HeLa cells, untreated or stimulated with HGF (A), using #3077 (upper) and Met<br />
(25H2) Mouse mAb #3127 (lower). Confocal IF analysis of MKN-45 cells, untreated (B) or<br />
treated with SU11274 (1 μM, 3 hr) (C), using #3077. Blue pseudocolor = DRAQ5 ® #4084<br />
(fluorescent DNA dye).<br />
C<br />
Treatment with a<br />
Met inhibitor prevents<br />
Met activation and<br />
phosphorylation at<br />
Tyr1234/1235.<br />
The nonreceptor tyrosine kinase<br />
Zap-70 is expressed in T cells.<br />
30<br />
– +<br />
Zap-70 (D1C10E) XP ® Rabbit mAb (Alexa Fluor ® 488 Conjugate) #9473:<br />
Flow cytometric analysis of Ramos (B cells; blue) and Jurkat (T cells; green) cells<br />
using #9473.<br />
mIL-3<br />
Events<br />
Zap-70<br />
200<br />
140<br />
100<br />
80<br />
60<br />
50<br />
40<br />
– +<br />
Met<br />
HGF<br />
Nonreceptor Tyrosine Kinases<br />
The cytoplasmic nonreceptor tyrosine kinases transduce signals generated by RTKs and other receptors<br />
from the cell surface to the nucleus. Receptor-associated tyrosine kinases are phosphorylated within the<br />
activation loop of their kinase catalytic domain, resulting in activation and propagation of downstream<br />
signals through phosphorylation of other kinases, adaptor proteins, or transcription factors. In addition<br />
to their kinase domain, nonreceptor tyrosine kinases often contain various domains that mediate<br />
protein-protein or protein-lipid interactions, which allows association with activated receptors or downstream<br />
signaling nodes. For example, SH2 domains bind phospho-tyrosine residues, while PH domains<br />
direct interactions with membrane lipids.<br />
PDGF treatment results in phosphorylation<br />
of Src family proteins at Tyr416.<br />
Phospho-Src Family (Tyr416) (D49G4) Rabbit mAb #6943: WB analysis of extracts<br />
NIH/3T3 cells, serum-starved or treated with human Platelet-Derived Growth Factor BB<br />
hPDGF-BB #8912 (100 ng/ml, 15 min), using #6943 (upper) or Src (36D10) Rabbit mAb<br />
#2109 (lower).<br />
Select Reviews<br />
Arteaga, C.L. and Engelman, J.A. (2014) Cancer Cell 25, 282−303. • Davies, K.D. and Doebele, R.C. (2013) Clin. Cancer<br />
Res. 19, 4040−4045. • Hallberg, B. and Palmer, R.H. (2013) Nat. Rev. Cancer 13, 685−700. • Liu, S.T., Pham, H., Pandol,<br />
S.J., and Ptasznik, A. (2014) Front. Physiol. 4, 416. • Miaczynska, M. (2013) Cold Spring Harb. Perspect. Biol. 5, a009035.<br />
• Panjarian, S., Lacob, R.E., Chen, S., Engen, J.R., and Smithgall, T.E. (2013) J. Biol. Chem. 288, 5443−5450. • Shaw, A.T.,<br />
Hsu, P.P., Awad, M.M., and Engelman, J.A. (2013) Nat. Rev. Cancer 13, 772−787.<br />
kDa<br />
100<br />
80<br />
60<br />
50<br />
40<br />
30<br />
20<br />
100<br />
80<br />
60<br />
50<br />
40<br />
30<br />
20<br />
– +<br />
Phospho-Src<br />
(Tyr416)<br />
Src<br />
hPDGF-BB<br />
Commonly Studied Tyrosine Kinases Targets<br />
Target M P E S C<br />
ACPP<br />
•<br />
ALK • • •<br />
Phospho-ALK (Tyr1078) • •<br />
Phospho-ALK (Tyr1096) • •<br />
Phospho-ALK (Tyr1278) • •<br />
Phospho-ALK (Tyr1282/Tyr1283) • •<br />
•<br />
Phospho-ALK (Tyr1278/Tyr1282/<br />
Tyr1283)<br />
Phospho-ALK (Tyr1586) • • •<br />
Phospho-ALK (Tyr1604) • • •<br />
Axl<br />
• • • •<br />
Phospho-Axl (pan Tyr)<br />
•<br />
Phospho-Axl (Tyr702) •<br />
DDR1<br />
• • •<br />
Phospho-DDR1 (pan Tyr)<br />
•<br />
Phospho-DDR1 (Tyr792) •<br />
DDR2<br />
•<br />
EGFR<br />
• • • • •<br />
Phospho-EGFR (Thr669) • •<br />
Phospho-EGFR (Tyr845) • • •<br />
Phospho-EGFR (Tyr992) •<br />
Phospho-EGFR (Tyr998) •<br />
Phospho-EGFR (Tyr1045) •<br />
Phospho-EGFR (Ser1046/1047) •<br />
Phospho-EGFR (Tyr1068) • • • •<br />
Phospho-EGFR (Tyr1086) •<br />
Phospho-EGFR (Tyr1148) •<br />
Phospho-EGFR (Tyr1173) • •<br />
• • •<br />
EGF Receptor<br />
(E746-A750del Specific)<br />
Target M P E S C<br />
EGF Receptor (L858R Mutant Specific) • •<br />
EphA2<br />
•<br />
Phospho-EphA2 (Tyr588) •<br />
Phospho-EphA2 (Tyr594) •<br />
Phospho-EphA2 (Tyr772) •<br />
Phospho-EphA2 (Ser897) •<br />
Phospho-EphA3 (Tyr779) •<br />
EphA3/EphA4/EphA5 •<br />
EphB1<br />
•<br />
EphB6<br />
•<br />
Phospho-Ephrin B (Tyr324/329) •<br />
Eps8<br />
•<br />
EREG<br />
•<br />
Etk/BMX<br />
•<br />
Phospho-Etk/BMX (Tyr40) •<br />
FGFR1 • • • •<br />
FGFR1 (pan Tyr)<br />
•<br />
FGFR1 (Tyr653/Tyr654) • • •<br />
FGFR1 (Tyr766)<br />
•<br />
FGFR2 • • •<br />
Phospho-FGFR2 (Pan Tyr)<br />
•<br />
FGFR3<br />
•<br />
FGFR4 • • • •<br />
FLT3 • •<br />
Phospho-FLT3 (pan Tyr)<br />
•<br />
Phospho-FLT3 (Tyr589/Tyr591) •<br />
Phospho-FLT3 (Tyr591) • • •<br />
Phospho-FLT3 (Tyr842) •<br />
Phospho-FLT3 (Tyr969) •<br />
HER2/ErbB2<br />
• • • • •<br />
These protein targets represent key<br />
nodes within tyrosine kinases signaling<br />
pathways and are commonly studied<br />
in tyrosine kinases research. Primary<br />
antibodies, antibody conjugates, and<br />
antibody sampler kits containing these<br />
targets are available from <strong>CST</strong>.<br />
Listing as of September 2014. See our<br />
website for current product information.<br />
M Monoclonal Antibody<br />
P Polyclonal Antibody<br />
E PathScan ® ELISA Kits<br />
S SignalSilence ® siRNA<br />
C Antibody Conjugate<br />
68 For Research Use Only. Not For Use in Diagnostic Procedures. See pages 302 & 303 for Pathway Diagrams, Application, and Reactivity keys.<br />
www.cellsignal.com/csttyrosine 69